US stock · US markets · public data

AMGN

AMGEN Inc · Healthcare

Reference price$426.27Updated according to the public source
P/E26.48
P/B19.72
ROE91.47%
DY 12M2.30%
Net margin—
Net debt/equity—
Market capUS$ 230.5 B
Volume (shares)1,200,805
SectorHealthcare
Overview

About AMGN

Demonstrações públicas consolidadas + SEC Company Facts

AMGEN Inc (AMGN) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
06/23
09/23
12/23
03/24
06/24
09/24
12/24
03/25
06/25
09/25
12/25
03/26
Income in shown records$27.57
DY 12M2.30%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-03-31Dividendo declarado$2.52
Period ending 2025-12-31Dividendo declarado$2.52
Period ending 2025-09-30Dividendo declarado$2.38
Period ending 2025-06-30Dividendo declarado$2.38
Period ending 2025-03-31Dividendo declarado$2.38
Period ending 2024-12-31Dividendo declarado$2.25

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$28,190,000,000.00$33,424,000,000.00$36,751,000,000.00—
Operating Income$7,897,000,000.00$7,258,000,000.00$9,080,000,000.00—
Net Income$6,717,000,000.00$4,090,000,000.00$7,711,000,000.00—
EPS Diluted$12.49 / share$7.56 / share$14.23 / share—

Balance sheet

Account2023202420252026
Total Assets$97,154,000,000.00$91,839,000,000.00$90,586,000,000.00—
Total Equity$6,232,000,000.00$5,877,000,000.00$8,658,000,000.00—
Long-term Debt$64,613,000,000.00$60,099,000,000.00$54,604,000,000.00—
Current Debt$1,443,000,000.00$3,550,000,000.00$4,599,000,000.00—
Shares Outstanding533,976,238 shares535,918,901 shares537,204,943 shares539,067,675 shares
Cash & Investments————
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$8,471,000,000.00$11,490,000,000.00$9,958,000,000.00—
Capital Expenditures$1,112,000,000.00$1,096,000,000.00$1,858,000,000.00—
Dividends Paid$4,556,000,000.00$4,832,000,000.00$5,124,000,000.00—
Free Cash Flow$7,359,000,000.00$10,394,000,000.00$8,100,000,000.00—
FAQ

Frequently asked questions

What is the price of AMGN?

The reference price available for AMGN is $426.27.

What is the P/E of AMGN?

The P/E ratio of AMGN is 26.48. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of AMGN?

The P/B of AMGN is 19.72. This compares price with reported book value per share.

What is the ROE of AMGN?

The ROE (Return on Equity) of AMGN is 91.47%. This relates the reported net result to shareholders' equity.

What is the dividend yield of AMGN?

The dividend yield of AMGN is 2.30%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of AMGN?

The market capitalization of AMGN is US$ 230.5 B.

What sector is AMGN in?

AMGN operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.